DOI:
10.1055/s-00000045
Der Nuklearmediziner
LinksClose Window
References
Hofman MS, Violet J, Hicks RJ. et al.
[(177)Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study.
Lancet Oncol 2018;
19: 825-833
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.